Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1,658,393
-
Shares change
-
+207,764
-
Total reported value, excl. options
-
$13,121,000
-
Value change
-
-$563,118
-
Number of buys
-
23
-
Number of sells
-
-7
-
Price
-
$7.98
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q4 2021
37 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,658,393 shares
of 10,781,082 outstanding shares and own 15.38% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (368,704 shares), SANDERS MORRIS HARRIS LLC (336,425 shares), NewEdge Advisors, LLC (167,106 shares), CARLSON CAPITAL L P (125,000 shares), TWO SIGMA INVESTMENTS, LP (69,611 shares), Anson Funds Management LP (64,999 shares), GEODE CAPITAL MANAGEMENT, LLC (57,043 shares), MORGAN STANLEY (51,340 shares), Lynwood Capital Management Inc. (50,000 shares), and Redmond Asset Management, LLC (49,187 shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.